Quintrio
Home

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

NeuroOne Medical Technologies Corporation Common Stock

NMTC

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $0.71 – $0.80
Volume 21,741
Market cap $7M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$6.83M
Price / earnings
—
Price / book
1.81×
Price / sales
0.55×
EV / sales
0.38×
EV / EBITDA
-0.62×

Profitability

Earnings per share
-$0.82
Return on assets
-120.36%
Return on equity
-197.62%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
2.84×
Quick ratio
1.71×
Cash ratio
1×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$7.16M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NMTC, quarterly periods
Line itemQ3 FY2026 Jun 30, 2026Q2 FY2026 Mar 31, 2026Q1 FY2026 Dec 31, 2025Q4 FY2025 Sep 30, 2025Q3 FY2025 Jun 30, 2025Q2 FY2025 Mar 31, 2025Q1 FY2025 Dec 31, 2024Q4 FY2024 Sep 30, 2024
Revenue$1.97M$1.86M$2.89M$5.74M$1.7M$1.39M$3.27M$272.28K
Cost of revenue$790.5K$871.79K$1.32M$1.21M$781.22K$615.49K$1.35M$131.22K
Gross profit$1.18M$990.26K$1.57M$4.53M$914.84K$771.06K$1.93M$141.06K
Selling, general and administrative$2.18M$1.92M$1.89M$1.78M$1.62M$1.94M$2.04M$1.84M
Research and development$1.43M$1.47M$1.39M$1.12M$1.18M$1.51M$1.17M$1.11M
Total operating expenses$3.61M$3.39M$3.28M$5.9M$2.8M$3.45M$215.68K$2.96M
Operating income-$2.42M-$2.4M-$1.71M-$1.37M-$1.89M-$2.68M$1.71M-$2.82M
Interest expense$0$0$0-$334.06K-$9.33K$0-$324.74K-$228.99K
Income before taxes-$2.01M-$2.38M-$1.44M-$1.62M-$1.5M-$2.27M$1.79M-$3.35M
Income taxes$0$0$0$0$0$0$0$0
Net income-$2.01M-$2.38M-$1.44M-$1.62M-$1.5M-$2.27M$1.79M-$3.35M
Net income attributable to common shareholders-$2.01M-$2.38M-$1.44M-$1.62M-$1.5M-$2.27M$1.79M-$3.35M
EBITDA-$2.38M-$2.34M-$1.64M-$1.31M-$1.82M-$2.61M$1.78M-$2.75M
Basic earnings per share-$0.23-$0.28-$0.18-$0.19-$0.19-$0.44$0.36-$0.67
Diluted earnings per share-$0.28-$0.28-$0.18-$0.19-$0.19-$0.44$0.36-$0.67

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

NeuroOne Q3 Revenue Jumps 105 Percent

NeuroOne Medical Technologies reported strong Q3 2025 performance with 105% product revenue growth, improved gross margins, and promising clinical milestones for its OneRF ablation system, including the first patient achieving 12-month seizure freedom.

GlobeNewswire Inc.

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter fiscal year 2024 ended March 31, 2024.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 16, 20261-for-6reverse split
Apr 1, 20211-for-3reverse split